HOSSEIN MAYMANI, MD

Leuprolide acetate (for depot suspension), 7.5 mg

Nuclear medicine study from skull base to mid-thigh with ct scan

Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l

Administration of chemotherapy into vein, 1 hour or less

Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

Injection, zoledronic acid, 1 mg

New patient office or other outpatient visit, 60-74 minutes

New patient office or other outpatient visit, 45-59 minutes

Administration of additional new drug or substance into vein, 1 hour or less

Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less

Established patient office or other outpatient visit, 40-54 minutes

Injection, carboplatin, 50 mg

Flow cytometry technique for dna or cell analysis, first marker

Administration of additional new drug or substance into vein using push technique

Infusion into a vein for hydration, 31-60 minutes

Established patient office or other outpatient visit, 30-39 minutes

Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle

Flow cytometry technique for dna or cell analysis, each additional marker

Administration of chemotherapy into vein, each additional hour

Immunologic analysis technique on serum (immunofixation)

Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less

Established patient office or other outpatient visit, 20-29 minutes

Injection, pembrolizumab, 1 mg

Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle

Injection, palonosetron hcl, 25 mcg

Irrigation of implanted venous access drug delivery device

Injection of additional new drug or substance into vein

Infusion into a vein for therapy, prevention, or diagnosis, each additional hour

Protein measurement, serum

Carcinoembryonic antigen (cea) protein level

Injection of drug or substance under skin or into muscle

Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion

Psa (prostate specific antigen) measurement, total

Blood test, thyroid stimulating hormone (tsh)

Cyanocobalamin (vitamin b-12) level

Infusion into a vein for hydration, each additional hour

Folic acid level, serum

Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services

Thyroxine (thyroid chemical), free

Blood test, comprehensive group of blood chemicals

Measurement of immunoglobulin light chains

Ferritin (blood protein) level

Gammaglobulin (immune system protein) measurement

Total protein level, blood

Injection, oxaliplatin, 0.5 mg

Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count

Iron binding capacity

Lactate dehydrogenase (enzyme) level

Iron level

Injection, granisetron hydrochloride, 100 mcg